A citation-based method for searching scientific literature

Anamaria Jurcau. Biomedicines 2022
Times Cited: 3







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease.
Su Yang, Renbao Chang, Huiming Yang, Ting Zhao, Yan Hong, Ha Eun Kong, Xiaobo Sun, Zhaohui Qin, Peng Jin, Shihua Li,[...]. J Clin Invest 2017
189
66

Permanent inactivation of Huntington's disease mutation by personalized allele-specific CRISPR/Cas9.
Jun Wan Shin, Kyung-Hee Kim, Michael J Chao, Ranjit S Atwal, Tammy Gillis, Marcy E MacDonald, James F Gusella, Jong-Min Lee. Hum Mol Genet 2016
147
66

CRISPR-Cas9-Mediated Genome Editing Increases Lifespan and Improves Motor Deficits in a Huntington's Disease Mouse Model.
Freja K Ekman, David S Ojala, Maroof M Adil, Paola A Lopez, David V Schaffer, Thomas Gaj. Mol Ther Nucleic Acids 2019
51
66

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects.
Hongyi Li, Yang Yang, Weiqi Hong, Mengyuan Huang, Min Wu, Xia Zhao. Signal Transduct Target Ther 2020
426
33

Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.
F Ann Ran, Patrick D Hsu, Chie-Yu Lin, Jonathan S Gootenberg, Silvana Konermann, Alexandro E Trevino, David A Scott, Azusa Inoue, Shogo Matoba, Yi Zhang,[...]. Cell 2013
33


Efficient genome editing in zebrafish using a CRISPR-Cas system.
Woong Y Hwang, Yanfang Fu, Deepak Reyon, Morgan L Maeder, Shengdar Q Tsai, Jeffry D Sander, Randall T Peterson, J-R Joanna Yeh, J Keith Joung. Nat Biotechnol 2013
33

In vivo genome editing improves motor function and extends survival in a mouse model of ALS.
Thomas Gaj, David S Ojala, Freja K Ekman, Leah C Byrne, Prajit Limsirichai, David V Schaffer. Sci Adv 2017
89
33

Mammalian base excision repair: the forgotten archangel.
Grigory L Dianov, Ulrich Hübscher. Nucleic Acids Res 2013
218
33

PINK1 gene mutation by pair truncated sgRNA/Cas9-D10A in cynomolgus monkeys.
Zhen-Zhen Chen, Jian-Ying Wang, Yu Kang, Qiao-Yan Yang, Xue-Ying Gu, Da-Long Zhi, Li Yan, Cheng-Zu Long, Bin Shen, Yu-Yu Niu. Zool Res 2021
6
33

Targeted attenuation of elevated histone marks at SNCA alleviates α-synuclein in Parkinson's disease.
Subhrangshu Guhathakurta, Jinil Kim, Levi Adams, Sambuddha Basu, Min Kyung Song, Evan Adler, Goun Je, Mariana Bernardo Fiadeiro, Yoon-Seong Kim. EMBO Mol Med 2021
14
33

In Vitro CRISPR/Cas9-Directed Gene Editing to Model LRRK2 G2019S Parkinson's Disease in Common Marmosets.
Scott C Vermilyea, Alexander Babinski, Nina Tran, Samantha To, Scott Guthrie, Jillian H Kluss, Jenna Kropp Schmidt, Gregory J Wiepz, Michael G Meyer, Megan E Murphy,[...]. Sci Rep 2020
21
33

Generation of App knock-in mice reveals deletion mutations protective against Alzheimer's disease-like pathology.
Kenichi Nagata, Mika Takahashi, Yukio Matsuba, Fumi Okuyama-Uchimura, Kaori Sato, Shoko Hashimoto, Takashi Saito, Takaomi C Saido. Nat Commun 2018
18
33

Direct observation of R-loop formation by single RNA-guided Cas9 and Cascade effector complexes.
Mark D Szczelkun, Maria S Tikhomirova, Tomas Sinkunas, Giedrius Gasiunas, Tautvydas Karvelis, Patrizia Pschera, Virginijus Siksnys, Ralf Seidel. Proc Natl Acad Sci U S A 2014
260
33

Evaluation of off-target and on-target scoring algorithms and integration into the guide RNA selection tool CRISPOR.
Maximilian Haeussler, Kai Schönig, Hélène Eckert, Alexis Eschstruth, Joffrey Mianné, Jean-Baptiste Renaud, Sylvie Schneider-Maunoury, Alena Shkumatava, Lydia Teboul, Jim Kent,[...]. Genome Biol 2016
822
33

Next Generation Precision Medicine: CRISPR-mediated Genome Editing for the Treatment of Neurodegenerative Disorders.
Sudhanshu P Raikwar, Nidhi S Kikkeri, Ragha Sakuru, Daniyal Saeed, Haris Zahoor, Keerthivaas Premkumar, Shireen Mentor, Ramasamy Thangavel, Iuliia Dubova, Mohammad Ejaz Ahmed,[...]. J Neuroimmune Pharmacol 2019
11
33


Alzheimer's Disease Seen through the Eye: Ocular Alterations and Neurodegeneration.
Daniel Romaus-Sanjurjo, Uxía Regueiro, Maite López-López, Laura Vázquez-Vázquez, Alberto Ouro, Isabel Lema, Tomás Sobrino. Int J Mol Sci 2022
5
33

Pathway from TDP-43-Related Pathology to Neuronal Dysfunction in Amyotrophic Lateral Sclerosis and Frontotemporal Lobar Degeneration.
Yuichi Riku, Danielle Seilhean, Charles Duyckaerts, Susana Boluda, Yohei Iguchi, Shinsuke Ishigaki, Yasushi Iwasaki, Mari Yoshida, Gen Sobue, Masahisa Katsuno. Int J Mol Sci 2021
4
33

Efficacy and long-term safety of CRISPR/Cas9 genome editing in the SOD1-linked mouse models of ALS.
Han-Xiang Deng, Hong Zhai, Yong Shi, Guoxiang Liu, Jessica Lowry, Bin Liu, Éanna B Ryan, Jianhua Yan, Yi Yang, Nigel Zhang,[...]. Commun Biol 2021
7
33

The CRISPR-Cas Mechanism for Adaptive Immunity and Alternate Bacterial Functions Fuels Diverse Biotechnologies.
Sydney Newsom, Hari Priya Parameshwaran, Lindsie Martin, Rakhi Rajan. Front Cell Infect Microbiol 2021
16
33

Mechanism of foreign DNA selection in a bacterial adaptive immune system.
Dipali G Sashital, Blake Wiedenheft, Jennifer A Doudna. Mol Cell 2012
172
33

Evolution and classification of the CRISPR-Cas systems.
Kira S Makarova, Daniel H Haft, Rodolphe Barrangou, Stan J J Brouns, Emmanuelle Charpentier, Philippe Horvath, Sylvain Moineau, Francisco J M Mojica, Yuri I Wolf, Alexander F Yakunin,[...]. Nat Rev Microbiol 2011
33

Endogenous Type I CRISPR-Cas: From Foreign DNA Defense to Prokaryotic Engineering.
Yanli Zheng, Jie Li, Baiyang Wang, Jiamei Han, Yile Hao, Shengchen Wang, Xiangdong Ma, Shihui Yang, Lixin Ma, Li Yi,[...]. Front Bioeng Biotechnol 2020
33
33

Genetic Correction of SOD1 Mutant iPSCs Reveals ERK and JNK Activated AP1 as a Driver of Neurodegeneration in Amyotrophic Lateral Sclerosis.
Akshay Bhinge, Seema C Namboori, Xiaoyu Zhang, Antonius M J VanDongen, Lawrence W Stanton. Stem Cell Reports 2017
79
33

Impaired striatal dopamine release in homozygous Vps35 D620N knock-in mice.
Nobutaka Ishizu, Daishi Yui, Akira Hebisawa, Hidenori Aizawa, Wanpeng Cui, Yuko Fujita, Kenji Hashimoto, Itsuki Ajioka, Hidehiro Mizusawa, Takanori Yokota,[...]. Hum Mol Genet 2016
40
33

Applications of CRISPR-Cas systems in neuroscience.
Matthias Heidenreich, Feng Zhang. Nat Rev Neurosci 2016
159
33

Amyotrophic lateral sclerosis.
Orla Hardiman, Ammar Al-Chalabi, Adriano Chio, Emma M Corr, Giancarlo Logroscino, Wim Robberecht, Pamela J Shaw, Zachary Simmons, Leonard H van den Berg. Nat Rev Dis Primers 2017
531
33

Brain-wide Cas9-mediated cleavage of a gene causing familial Alzheimer's disease alleviates amyloid-related pathologies in mice.
Yangyang Duan, Tao Ye, Zhe Qu, Yuewen Chen, Abigail Miranda, Xiaopu Zhou, Ka-Chun Lok, Yu Chen, Amy K Y Fu, Viviana Gradinaru,[...]. Nat Biomed Eng 2022
11
33

In vivo neuronal gene editing via CRISPR-Cas9 amphiphilic nanocomplexes alleviates deficits in mouse models of Alzheimer's disease.
Hanseul Park, Jungju Oh, Gayong Shim, Byounggook Cho, Yujung Chang, Siyoung Kim, Soonbong Baek, Hongwon Kim, Jeain Shin, Hwan Choi,[...]. Nat Neurosci 2019
110
33




Co-editing PINK1 and DJ-1 Genes Via Adeno-Associated Virus-Delivered CRISPR/Cas9 System in Adult Monkey Brain Elicits Classical Parkinsonian Phenotype.
Hao Li, Shihao Wu, Xia Ma, Xiao Li, Tianlin Cheng, Zhifang Chen, Jing Wu, Longbao Lv, Ling Li, Liqi Xu,[...]. Neurosci Bull 2021
9
33


Applications of the CRISPR/Cas system beyond gene editing.
Tobias Anton, Elisabeth Karg, Sebastian Bultmann. Biol Methods Protoc 2018
14
33

The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli.
Rimantas Sapranauskas, Giedrius Gasiunas, Christophe Fremaux, Rodolphe Barrangou, Philippe Horvath, Virginijus Siksnys. Nucleic Acids Res 2011
458
33


CRISPR/Cas9-Mediated Gene Correction to Understand ALS.
Yeomin Yun, Yoon Ha. Int J Mol Sci 2020
16
33

Identification of 86 candidates for small non-messenger RNAs from the archaeon Archaeoglobus fulgidus.
Thean-Hock Tang, Jean-Pierre Bachellerie, Timofey Rozhdestvensky, Marie-Line Bortolin, Harald Huber, Mario Drungowski, Thorsten Elge, Jürgen Brosius, Alexander Hüttenhofer. Proc Natl Acad Sci U S A 2002
251
33

CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer's Disease.
Bence György, Camilla Lööv, Mikołaj P Zaborowski, Shuko Takeda, Benjamin P Kleinstiver, Caitlin Commins, Ksenia Kastanenka, Dakai Mu, Adrienn Volak, Vilmantas Giedraitis,[...]. Mol Ther Nucleic Acids 2018
75
33

Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664.
Veronica Galvan, Olivia F Gorostiza, Surita Banwait, Marina Ataie, Anna V Logvinova, Sandhya Sitaraman, Elaine Carlson, Sarah A Sagi, Nathalie Chevallier, Kunlin Jin,[...]. Proc Natl Acad Sci U S A 2006
192
33

Correction of amyotrophic lateral sclerosis related phenotypes in induced pluripotent stem cell-derived motor neurons carrying a hexanucleotide expansion mutation in C9orf72 by CRISPR/Cas9 genome editing using homology-directed repair.
Nidaa A Ababneh, Jakub Scaber, Rowan Flynn, Andrew Douglas, Paola Barbagallo, Ana Candalija, Martin R Turner, David Sims, Ruxandra Dafinca, Sally A Cowley,[...]. Hum Mol Genet 2020
19
33

A guild of 45 CRISPR-associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic genomes.
Daniel H Haft, Jeremy Selengut, Emmanuel F Mongodin, Karen E Nelson. PLoS Comput Biol 2005
629
33

CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease In Vivo.
Hyung Ho Yoon, Sunghyeok Ye, Sunhwa Lim, Ara Jo, Hawon Lee, Felix Hong, Seung Eun Lee, Soo-Jin Oh, Na-Rae Kim, Kyoungmi Kim,[...]. CRISPR J 2022
4
33

Application of CRISPR/Cas9 in Alzheimer's Disease.
Likui Lu, Xi Yu, Yongle Cai, Miao Sun, Hao Yang. Front Neurosci 2021
1
100

Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression.
Lei S Qi, Matthew H Larson, Luke A Gilbert, Jennifer A Doudna, Jonathan S Weissman, Adam P Arkin, Wendell A Lim. Cell 2013
33

Modeling the β-secretase cleavage site and humanizing amyloid-beta precursor protein in rat and mouse to study Alzheimer's disease.
Lutgarde Serneels, Dries T'Syen, Laura Perez-Benito, Tom Theys, Matthew G Holt, Bart De Strooper. Mol Neurodegener 2020
16
33

CRISPR-Cas9 Mediated Gene-Silencing of the Mutant Huntingtin Gene in an In Vitro Model of Huntington's Disease.
Nivya Kolli, Ming Lu, Panchanan Maiti, Julien Rossignol, Gray L Dunbar. Int J Mol Sci 2017
43
33

Neuroimaging Modalities in Alzheimer's Disease: Diagnosis and Clinical Features.
JunHyun Kim, Minhong Jeong, Wesley R Stiles, Hak Soo Choi. Int J Mol Sci 2022
2
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.